- NCT00231608
- Primary Citation Trial has yet to be published
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment68% FemaleN/A% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-OBMA-001Data PartnerJohnson & JohnsonCondition StudiedObesityMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Clinical Study Report Available